skinny.

Latest / Lung Cancer Considered

IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy

This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a discussion of the formulation and its place in the management of patients with lung cancer. Guests: Cheryl Ho, MD, FRCPC Thoracic Oncologist, BC Cancer Clinical Associate Professor and Fellowship Program Director University of British Columbia Maria Velez Velez, MD, MS Clinical Instructor, Division of Hematology/Oncology David Geffen School of Medicine at UCLA

Log in to save or queue this episode.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.